
Shobha Kantamneni
Examiner (ID: 1732, Phone: (571)272-2930 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1627, 1617, 1623 |
| Total Applications | 1212 |
| Issued Applications | 306 |
| Pending Applications | 120 |
| Abandoned Applications | 793 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6755287
[patent_doc_number] => 20030003064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Cosmetic compositions comprising discrete color domains and associated methods'
[patent_app_type] => new
[patent_app_number] => 10/174247
[patent_app_country] => US
[patent_app_date] => 2002-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15584
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20030003064.pdf
[firstpage_image] =>[orig_patent_app_number] => 10174247
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/174247 | Cosmetic compositions comprising discrete color domains and associated methods | Jun 17, 2002 | Abandoned |
Array
(
[id] => 6801687
[patent_doc_number] => 20030096852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Human growth hormone antagonists'
[patent_app_type] => new
[patent_app_number] => 10/172247
[patent_app_country] => US
[patent_app_date] => 2002-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7479
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20030096852.pdf
[firstpage_image] =>[orig_patent_app_number] => 10172247
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/172247 | Human growth hormone antagonists | Jun 13, 2002 | Abandoned |
Array
(
[id] => 6842478
[patent_doc_number] => 20030147825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Personal care compostions containing inverse emulsion polymers'
[patent_app_type] => new
[patent_app_number] => 10/161225
[patent_app_country] => US
[patent_app_date] => 2002-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16606
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20030147825.pdf
[firstpage_image] =>[orig_patent_app_number] => 10161225
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/161225 | Personal care compostions containing inverse emulsion polymers | May 30, 2002 | Abandoned |
Array
(
[id] => 6678191
[patent_doc_number] => 20030228332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Purified, partially esterified polyol polyester fatty acid compositions'
[patent_app_type] => new
[patent_app_number] => 10/156479
[patent_app_country] => US
[patent_app_date] => 2002-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13940
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20030228332.pdf
[firstpage_image] =>[orig_patent_app_number] => 10156479
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/156479 | Purified, partially esterified polyol polyester fatty acid compositions | May 27, 2002 | Abandoned |
Array
(
[id] => 6813237
[patent_doc_number] => 20030072787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Animal food and method'
[patent_app_type] => new
[patent_app_number] => 10/142685
[patent_app_country] => US
[patent_app_date] => 2002-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7907
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20030072787.pdf
[firstpage_image] =>[orig_patent_app_number] => 10142685
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/142685 | Animal food and method | May 9, 2002 | Abandoned |
Array
(
[id] => 6640708
[patent_doc_number] => 20030212127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Method of treating actinic keratosis'
[patent_app_type] => new
[patent_app_number] => 10/143680
[patent_app_country] => US
[patent_app_date] => 2002-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5550
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20030212127.pdf
[firstpage_image] =>[orig_patent_app_number] => 10143680
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/143680 | Method of treating actinic keratosis | May 8, 2002 | Abandoned |
| 10/129724 | Neurophilin ligands for treating ocular conditions | May 7, 2002 | Abandoned |
| 10/049556 | Drug for treating fractures | May 6, 2002 | Abandoned |
Array
(
[id] => 6329235
[patent_doc_number] => 20020198160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => 'Compositions and methods for enhancing the bioavailability of pharmaceutical agents'
[patent_app_type] => new
[patent_app_number] => 10/134931
[patent_app_country] => US
[patent_app_date] => 2002-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7666
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20020198160.pdf
[firstpage_image] =>[orig_patent_app_number] => 10134931
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/134931 | Compositions and methods for enhancing the bioavailability of pharmaceutical agents | Apr 28, 2002 | Abandoned |
Array
(
[id] => 7465713
[patent_doc_number] => 20040198607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Herbicide composition'
[patent_app_type] => new
[patent_app_number] => 10/490702
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4360
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198607.pdf
[firstpage_image] =>[orig_patent_app_number] => 10490702
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/490702 | Herbicide composition | Apr 25, 2002 | Issued |
Array
(
[id] => 6262074
[patent_doc_number] => 20020187998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-12
[patent_title] => 'Local ophthalmic agent for treatment of ocular inflammation'
[patent_app_type] => new
[patent_app_number] => 10/120515
[patent_app_country] => US
[patent_app_date] => 2002-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5737
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20020187998.pdf
[firstpage_image] =>[orig_patent_app_number] => 10120515
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/120515 | Local ophthalmic agent for treatment of ocular inflammation | Apr 11, 2002 | Abandoned |
Array
(
[id] => 6830367
[patent_doc_number] => 20030181425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Antibiotic pharmaceutical composition with lysergol as bio-enhancer and method of treatment'
[patent_app_type] => new
[patent_app_number] => 10/103726
[patent_app_country] => US
[patent_app_date] => 2002-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2767
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20030181425.pdf
[firstpage_image] =>[orig_patent_app_number] => 10103726
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/103726 | Antibiotic pharmaceutical composition with lysergol as bio-enhancer and method of treatment | Mar 24, 2002 | Abandoned |
Array
(
[id] => 6159024
[patent_doc_number] => 20020147197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Methods and compositions for enhancing pharmaceutical treatments'
[patent_app_type] => new
[patent_app_number] => 10/104549
[patent_app_country] => US
[patent_app_date] => 2002-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18877
[patent_no_of_claims] => 231
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20020147197.pdf
[firstpage_image] =>[orig_patent_app_number] => 10104549
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/104549 | Methods and compositions for enhancing pharmaceutical treatments | Mar 19, 2002 | Abandoned |
Array
(
[id] => 42043
[patent_doc_number] => 07780971
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-24
[patent_title] => 'Composition containing fibers, spherical particles and platelets, and its uses'
[patent_app_type] => utility
[patent_app_number] => 10/100907
[patent_app_country] => US
[patent_app_date] => 2002-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5684
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 267
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/780/07780971.pdf
[firstpage_image] =>[orig_patent_app_number] => 10100907
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/100907 | Composition containing fibers, spherical particles and platelets, and its uses | Mar 19, 2002 | Issued |
Array
(
[id] => 6048638
[patent_doc_number] => 20020169140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Combination therapy for reduction of toxicity of chemotherapeutic agents'
[patent_app_type] => new
[patent_app_number] => 10/091855
[patent_app_country] => US
[patent_app_date] => 2002-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10644
[patent_no_of_claims] => 139
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20020169140.pdf
[firstpage_image] =>[orig_patent_app_number] => 10091855
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/091855 | Combination therapy for reduction of toxicity of chemotherapeutic agents | Mar 5, 2002 | Abandoned |
Array
(
[id] => 6381915
[patent_doc_number] => 20020120003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-29
[patent_title] => 'Methods for decreasing beta amyloid protein'
[patent_app_type] => new
[patent_app_number] => 10/086398
[patent_app_country] => US
[patent_app_date] => 2002-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2685
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20020120003.pdf
[firstpage_image] =>[orig_patent_app_number] => 10086398
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/086398 | Methods for decreasing beta amyloid protein | Feb 27, 2002 | Abandoned |
Array
(
[id] => 5859918
[patent_doc_number] => 20020123504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine'
[patent_app_type] => new
[patent_app_number] => 10/082685
[patent_app_country] => US
[patent_app_date] => 2002-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7226
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20020123504.pdf
[firstpage_image] =>[orig_patent_app_number] => 10082685
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/082685 | Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine | Feb 24, 2002 | Abandoned |
Array
(
[id] => 634174
[patent_doc_number] => 07129231
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-31
[patent_title] => 'Regulation of intracellular glucocorticoid concentrations'
[patent_app_type] => utility
[patent_app_number] => 10/081787
[patent_app_country] => US
[patent_app_date] => 2002-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 7168
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/129/07129231.pdf
[firstpage_image] =>[orig_patent_app_number] => 10081787
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/081787 | Regulation of intracellular glucocorticoid concentrations | Feb 21, 2002 | Issued |
Array
(
[id] => 641850
[patent_doc_number] => 07122531
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-17
[patent_title] => 'Regulation of intracellular glucocorticoid concentrations'
[patent_app_type] => utility
[patent_app_number] => 10/080875
[patent_app_country] => US
[patent_app_date] => 2002-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 7142
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/122/07122531.pdf
[firstpage_image] =>[orig_patent_app_number] => 10080875
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/080875 | Regulation of intracellular glucocorticoid concentrations | Feb 21, 2002 | Issued |
Array
(
[id] => 641851
[patent_doc_number] => 07122532
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-17
[patent_title] => 'Regulation of intracellular glucocorticoid concentrations'
[patent_app_type] => utility
[patent_app_number] => 10/080876
[patent_app_country] => US
[patent_app_date] => 2002-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 7175
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/122/07122532.pdf
[firstpage_image] =>[orig_patent_app_number] => 10080876
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/080876 | Regulation of intracellular glucocorticoid concentrations | Feb 21, 2002 | Issued |